Obesity Today: Chugai licenses CT-388 for Japan, GLP-1 access news (Oct 7–14, 2025)
Obesity news this week include Chugai in-licensing Roche’s dual incretin CT-388…
Lucid Diligence Brief: Novo Nordisk to acquire Akero Therapeutics for up to $5.2 billion
Lucid Diligence Brief: Novo Nordisk to acquire Akero Therapeutics for up to…
Obesity Weekly News - October 7th 2025
Obesity Update: MET-097i Breakthrough, New EASO Guidelines, & More! From…
Cardiovascular Weekly News - October 2nd 2025
Cardiovascular Update: CardiAMP cell therapy, GBD special report, EU steps up…
Latest Obesity News - Sept 15th to Sept 29th
Watch Our Video Summary Capturing Top Obesity News from the Last Two Weeks……
Obesity Weekly News - September 29th 2025
Obesity Update: Pfizer–Metsera Acquisition, Lilly’s $6.5B API Expansion, &…
Endocrinology Weekly Update - September 29th 2025
Endocrinology Update: Once-Weekly Kyinsu, Bayer’s Lynkuet, EASD’s clinical…
Cardiovascular Weekly News - September 25th 2025
Cardiovascular Update: NEURESCUE CE Mark, HFpEF Pacing Trial, Bicuspid Valve…
Obesity Weekly News - September 23rd 2025
Obesity Update: ASC47 Combo Gains, Quintuple Agonist, Mazdutide Launch,…
Public Health Weekly News - September 19th 2025
Public Health Update: Lifestyle and Alzheimer’s, Stem Cells Post-Stroke,…
Immunology Weekly News - September 17th 2025
🔬 This week in Immunology Updates: Immunology Licensing Deal, Phase II SKYWAY…
Obesity Weekly News - September 16th 2025
Obesity Update: ASC30’s Ultra-Long Dosing, Oral GLP-1 Pill Race, Korea…